NO20023144L - Et kompleks som omfatter OCIF og polysakkarid - Google Patents

Et kompleks som omfatter OCIF og polysakkarid

Info

Publication number
NO20023144L
NO20023144L NO20023144A NO20023144A NO20023144L NO 20023144 L NO20023144 L NO 20023144L NO 20023144 A NO20023144 A NO 20023144A NO 20023144 A NO20023144 A NO 20023144A NO 20023144 L NO20023144 L NO 20023144L
Authority
NO
Norway
Prior art keywords
ocif
polysaccharide
complex
Prior art date
Application number
NO20023144A
Other languages
English (en)
Other versions
NO20023144D0 (no
Inventor
Shinichi Yamamoto
Junichi Okada
Atsushi Kurihara
Taku Numazawa
Junichi Kondo
Eisuke Tsuda
Shinichi Mochizuki
Hirotaka Nishi
Hideki Miyazaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20023144D0 publication Critical patent/NO20023144D0/no
Publication of NO20023144L publication Critical patent/NO20023144L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20023144A 2001-06-29 2002-06-28 Et kompleks som omfatter OCIF og polysakkarid NO20023144L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001198985 2001-06-29

Publications (2)

Publication Number Publication Date
NO20023144D0 NO20023144D0 (no) 2002-06-28
NO20023144L true NO20023144L (no) 2002-12-30

Family

ID=19036337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023144A NO20023144L (no) 2001-06-29 2002-06-28 Et kompleks som omfatter OCIF og polysakkarid

Country Status (22)

Country Link
US (3) US20030045456A1 (no)
EP (1) EP1270015A3 (no)
KR (1) KR20030003124A (no)
CN (1) CN1442201A (no)
AR (1) AR034716A1 (no)
AU (1) AU783126B2 (no)
BR (1) BR0202439A (no)
CA (1) CA2392383A1 (no)
CO (1) CO5390084A1 (no)
CZ (1) CZ20022231A3 (no)
HK (1) HK1048762A1 (no)
HU (1) HUP0202119A2 (no)
IL (1) IL150448A0 (no)
MX (1) MXPA02006511A (no)
NO (1) NO20023144L (no)
PA (1) PA8549401A1 (no)
PE (1) PE20030254A1 (no)
PL (1) PL354799A1 (no)
RU (1) RU2232594C2 (no)
SG (1) SG98059A1 (no)
SK (1) SK9492002A3 (no)
ZA (1) ZA200205164B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
NZ511506A (en) 1998-10-28 2004-02-27 Sankyo Co Remedies for bone metabolic errors comprising OCIF
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
AU2003208621A1 (en) * 2002-03-01 2003-09-16 Sankyo Company, Limited A pharmaceutical composition
US7638480B2 (en) 2002-04-10 2009-12-29 Laboratoires Serono Sa Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
US7585840B2 (en) * 2002-04-10 2009-09-08 Merck Serono S.A. Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
WO2003103710A1 (ja) * 2002-06-07 2003-12-18 三共株式会社 骨破壊の治療または予防剤組成物の併用効果
KR100840830B1 (ko) * 2006-09-03 2008-06-23 재단법인서울대학교산학협력재단 고분자 히알루론산을 포함하는 골흡수 저해용 조성물
ITMI20121316A1 (it) * 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
CN115594776B (zh) * 2022-09-19 2024-03-15 山东大学 一种ROS响应性聚合物Mal-PHB-Dextran及细胞背包载药系统

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216297A (en) * 1879-06-10 Improvement in ironing-stands
US31725A (en) * 1861-03-19 Improvement in cultivators
US4207A (en) * 1845-09-27 lewis
US45456A (en) * 1864-12-13 Improved apparatus for carbureting air
US139325A (en) * 1873-05-27 Improvement in carriage-springs
US181418A (en) * 1876-08-22 Improvement in gas apparatus
TW318142B (no) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US20030207827A1 (en) * 1995-12-22 2003-11-06 William J. Boyle Osteoprotegerin
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
AU739304B2 (en) * 1997-09-24 2001-10-11 Sankyo Company Limited Method of diagnosing metabolic bone diseases
AU4061899A (en) * 1998-06-15 2000-01-05 Takeda Chemical Industries Ltd. Thienodipyridine derivatives, production and use thereof
NZ511506A (en) * 1998-10-28 2004-02-27 Sankyo Co Remedies for bone metabolic errors comprising OCIF
KR20010085996A (ko) * 1999-09-03 2001-09-07 스티븐 엠. 오드레 암 및 암관련 골손실을 예방 또는 치료하는 조성물 및 방법
WO2002026191A2 (en) * 2000-09-28 2002-04-04 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
AU2003208621A1 (en) * 2002-03-01 2003-09-16 Sankyo Company, Limited A pharmaceutical composition

Also Published As

Publication number Publication date
BR0202439A (pt) 2003-06-10
SG98059A1 (en) 2003-08-20
SK9492002A3 (en) 2003-02-04
IL150448A0 (en) 2002-12-01
PE20030254A1 (es) 2003-03-19
PL354799A1 (en) 2002-12-30
US20030139325A1 (en) 2003-07-24
CN1442201A (zh) 2003-09-17
PA8549401A1 (es) 2003-07-28
US20030045456A1 (en) 2003-03-06
NO20023144D0 (no) 2002-06-28
ZA200205164B (en) 2003-03-24
CZ20022231A3 (cs) 2003-02-12
RU2002117385A (ru) 2004-01-27
AU5071902A (en) 2003-01-02
AR034716A1 (es) 2004-03-17
HUP0202119A2 (hu) 2003-04-28
US20060084595A1 (en) 2006-04-20
EP1270015A2 (en) 2003-01-02
HK1048762A1 (zh) 2003-04-17
HU0202119D0 (no) 2002-08-28
EP1270015A3 (en) 2004-02-25
MXPA02006511A (es) 2004-08-11
CA2392383A1 (en) 2002-12-29
AU783126B2 (en) 2005-09-29
KR20030003124A (ko) 2003-01-09
CO5390084A1 (es) 2004-04-30
RU2232594C2 (ru) 2004-07-20

Similar Documents

Publication Publication Date Title
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
NO20033726L (no) Xantin-derivater, fremstilling og anvendelse derav som et medikament
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1443917T3 (da) Tamsulosintabletter
DE50203203D1 (de) Sende- und empfangseinheit
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20042906L (no) Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
DE60033711D1 (de) Halskette
NO20015931D0 (no) Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
NO20042907L (no) Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
FR2830063B1 (fr) Joint homocinetique
NO20023144L (no) Et kompleks som omfatter OCIF og polysakkarid
NO20035798L (no) Tablett som inneholder cetirizin og pseudoefedrin
NO20040214L (no) Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav
ATE543977T1 (de) Scharniergelenk
NO20033709L (no) Medisinske preparater omfattende Diklofenak og Ornoprostil
NO20013816L (no) Benzamidderivater og legemidler som inneholder disse
DE50213801D1 (de) Gelenk
FR2825763B1 (fr) Biellette a rotule
DE60225462D1 (de) Wasserlösliche kapseln
DE60219418D1 (de) Silanylphenole und -naphthole
FR2825761B1 (fr) Goupille elastique
FIU20010460U0 (fi) Saranarakenne
UA5324S (uk) Браслет

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application